A Prospective Study On the Surgical Treatment of Large Hypertensive Basal Ganglia Bleed: Surgical Treatment of Large Hypertensive Basal Ganglia Bleed

Muhammad  Munwar Ali; Muhammad  Muzaffer uddin; Zaheen  Shibli; Ramesh  Kumar; Qazi  Muhammad Zeeshan; Farrukh  Zulfiqar

doi:10.54393/pjhs.v3i04.158

Authors

Muhammad Munwar Ali Neurosurgery Department, Shaheed Mohtarma Benazir Bhutto Medical University, Larkana
Muhammad Muzaffer uddin Neurosurgery Department, Memon Medical Institute Hospital Karachi
Zaheen Shibli Neurosurgery Department, Karachi Medical and Dental College, Abbasi Shaheed Hospital
Ramesh Kumar Neurosurgery Department, Dow University of Health Sciences
Qazi Muhammad Zeeshan Neurosurgery Department, Dow University of Health Sciences
Farrukh Zulfiqar Neurosurgery Department, Dow University of Health Sciences

DOI:

https://doi.org/10.54393/pjhs.v3i04.158

Keywords:

Craniotomy, Basal ganglia bleed, ventricular hemorrhage, Glasgow Outcome Score, Glasgow Coma Scale

Abstract

Spontaneous intracerebral bleed is a communal subtype of stroke and is usually the deadliest. Objective: To determine the efficacy of surgical management of spontaneous hypertensive basal ganglia bleed and the factors contributing its outcome. Methods: A prospective study was carried out in the department of Neurosurgery for two-year duration from January 2020 to December 2021. 80 patients aged 18-65 years were included after matching criteria of inclusion of this study. The open craniotomy and evacuation was the surgical technique in all patients. After treatment, all cases were followed up for minimum six months. Patients were categorized as having good or bad scores on GOS. The data analysis was done using SPSS by assessing the effect of the observed variables including age, GCS, volume of blood, midline shift, ventricular extension and hydrocephalus. Results: 80 patients, 55 (68.8%) males and 25 (31.2%) females were done with surgical intervention. Their ages ranged from 18-65 years. Conferring to the patients GCS, they were divided into 3 groups: 26 (32.5%) patients with 5-8GCS; 38 (47.5%) patients with 9-12 GCS; and 16 (20%) patients with 13-15GCS. The volume of blood ranged from 30-90 cm³. 13 patients (16.3%) had ventricular extension, and 9 patients had hydrocephalus. In 34 patients (42.5%) had midline shift was <5 mm and 46 patients (57.5%) had > 5 mm. 49 patients (61.3%) had favorable results conferring to GOS scoring (4, 5), poor results in 31 (38.7%) cases, and 21 among those died (26.3%). Conclusions: Early evacuation with surgery results in a radical decrease in intracranial pressure and better prognosis. Patients with midline deviation >5mm, ventricular extension, hydrocephalus and reduced level of consciousness have worst prognosis.

References

Abdelrahman M. Surgical management for large hypertensive basal ganglionic hemorrhage: single center experience. Egyptian Journal of Neurosurgery. 2019 Dec; 34(1):1-8. doi: 10.1186/s41984-019-0044-9

Wu Y, Zhang S, Dong Y, Shen X, Han Y, Li Y, et al. Therapeutic Effect of Electronic Endoscopic Hematoma Removal on Hypertensive Basal Ganglia Cerebral Hemorrhage Based on Smart Medical Technology. Journal of Healthcare Engineering. 2021 Jun; 2021:7486249. doi: 10.1155/2021/7486249

Ratre S, Yadav N, Parihar VS, Dubey A, Yadav YR. Endoscopic surgery of spontaneous basal ganglionic hemorrhage. Neurology India. 2018 Dec; 66(6):1694-1703. doi: 10.4103/0028-3886.246288

Joshi S and Musuka TD. Guillain-Barré syndrome as a complication of hypertensive basal ganglia haemorrhage. Journal of Clinical Neuroscience. 2019 Jun; 64:54-56. doi: 10.1016/j.jocn.2019.02.018

Wu R, Qin H, Cai Z, Shi J, Cao J, Mao Y, et al. The Clinical Efficacy of Electromagnetic Navigation-Guided Hematoma Puncture Drainage in Patients with Hypertensive Basal Ganglia Hemorrhage. World Neurosurgery. 2018 Oct; 118:e115-e122. doi: 10.1016/j.wneu.2018.06.137

Wang T, Zhao QJ, Gu JW, Shi TJ, Yuan X, Wang J, et al. Neurosurgery medical robot Remebot for the treatment of 17 patients with hypertensive intracerebral hemorrhage. The International Journal of Medicine and Robotics. 2019 Oct; 15(5):e2024. doi: 10.1002/rcs.2024

Luzzi S, Elia A, Del Maestro M, Morotti A, Elbabaa SK, Cavallini A, et al. Indication, Timing, and Surgical Treatment of Spontaneous Intracerebral Hemorrhage: Systematic Review and Proposal of a Management Algorithm. World Neurosurgery. 2019 Jan; S1878-8750(19)30105-6. doi: 10.1016/j.wneu.2019.01.016

Sun G, Li X, Chen X, Zhang Y, Xu Z. Comparison of keyhole endoscopy and craniotomy for the treatment of patients with hypertensive cerebral hemorrhage. Medicine (Baltimore). 2019 Jan; 98(2):e14123. doi: 10.1097/MD.0000000000014123

Wei L, Zhang J, Geng J, Lin C, Zhang Y, Zhang B, et al. Hemoglobin Concentration Affects Hypertensive Basal Ganglia Hemorrhage After Surgery: Correlation Analysis in a High-Altitude Region. World Neurosurgery. 2019 Jul; 127:e835-e842. doi: 10.1016/j.wneu.2019.03.281

Gui C, Gao Y, Hu D, Yang X. Neuroendoscopic minimally invasive surgery and small bone window craniotomy hematoma clearance in the treatment of hypertensive cerebral hemorrhage. Pakistan Journal of Medical Sciences. 2019 Apr; 35(2):377-382. doi: 10.12669/pjms.35.2.463

Ma L, Hou Y, Zhu R, Chen X. Endoscopic Evacuation of Basal Ganglia Hematoma: Surgical Technique, Outcome, and Learning Curve. World Neurosurgery. 2017 May; 101:57-68. doi: 10.1016/j.wneu.2017.01.072

Leasure AC, Qureshi AI, Murthy SB, Kamel H, Goldstein JN, Woo D, et al. Association of Intensive Blood Pressure Reduction With Risk of Hematoma Expansion in Patients With Deep Intracerebral Hemorrhage. JAMA Neurology. 2019 Aug; 76(8):949-955. doi: 10.1001/jamaneurol.2019.1141

Sun Y, Xu B, Zhang Q. Nerve growth factor in combination with Oxiracetam in the treatment of Hypertensive Cerebral Hemorrhage. Pakistan Journal of Medical Sciences. 2018 Feb; 34(1):73-77. doi: 10.12669/pjms.341.13395

Qiu S, Liu T, Cao G, Wu K, Zhao T. Treatment of intracranial hemorrhage with neuroendoscopy guided by body surface projection. Medicine (Baltimore). 2019 May; 98(19):e15503. doi: 10.1097/MD.0000000000015503

An SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update. Journal of Stroke. 2017 Jan; 19(1):3-10. doi: 10.5853/jos.2016.00864

Aguilar MI and Brott TG. Update in intracerebral hemorrhage. The Neurohospitalist. 2011 Jul; 1(3):148-59. doi: 10.1177/1941875211409050

Rymer MM. Hemorrhagic stroke: intracerebral hemorrhage. Missouri medicine. 2011 Jan; 108(1):50.

Valadka AB, Gopinath SP, Robertson CS. Midline shift after severe head injury: pathophysiologic implications. Journal of Trauma and Acute Care Surgery. 2000 Jul; 49(1):1-0.

Salimi H and Klein RS. Disruption of the blood-brain barrier during neuroinflammatory and neuroinfectious diseases. InNeuroimmune Diseases 2019 (pp. 195-234). Springer, Cham. doi: 10.1007/978-3-030-19515-1_7

Welcome MO and Mastorakis NE. Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology. 2021 Aug; 29(4):939-963. doi: 10.1007/s10787-021-00806-x

Hinson HE, Hanley DF, Ziai WC. Management of intraventricular hemorrhage. Current Neurology and Neuroscience Reports. 2010 Mar; 10(2):73-82. doi: 10.1007/s11910-010-0086-6

Orringer DA, Golby A, Jolesz F. Neuronavigation in the surgical management of brain tumors: current and future trends. Expert Review of Medical Devices. 2012 Sep; 9(5):491-500. doi: 10.1586/erd.12.42

Lim-Hing K and Rincon F. Secondary Hematoma Expansion and Perihemorrhagic Edema after Intracerebral Hemorrhage: From Bench Work to Practical Aspects. Frontiers in Neurology. 2017 Apr; 8:74. doi: 10.3389/fneur.2017.00074

Farahmand D, Keil F, Göhring M, Dinc N, Seifert V, Marquardt G, et al. Prognostic risk factors for postoperative hemorrhage in stereotactic biopsies of lesions in the basal ganglia. Clinical Neurology and Neurosurgery. 2018 Nov; 174:180-184. doi: 10.1016/j.clineuro.2018.09.008

Mamytov M and Yrysov K. Optimal Times of Carrying Out of Operative Treatment of Patients with Hypertensive Hemorrhagic Stroke. Clinical Neurology and Neuroscience. 2019; 3(4):77-83.